Posted on April 26, 20214/26/21
Elijah J. Cummings Lower Drug Costs Now Act (HR 3) Reintroduced in United States
Posted on April 26, 20214/26/21
World EPA Congress DAY 2: Global Trends in Net Price
Posted on April 21, 20214/21/21
Bluebird to Withdraw Zynteglo from Germany After Price Negotiations Failed to Recognize Drug’s Value
Posted on April 21, 20214/21/21
Kymriah, Yescarta Subject to Cost-Effectiveness Assessment-Based Price Adjustments in Japan
Posted on April 20, 20214/20/21
Amgen’s Bemarituzumab Granted Breakthrough Designation in U.S.
Posted on April 20, 20214/20/21
NICE Launches 5-year Strategy
Posted on April 19, 20214/19/21
Two Bills Aiming to Lower Prescription Drug Costs Await Signatures from Biden
Posted on April 15, 20214/15/21
ICER Utilizes Real World Evidence to Update Assessment of HAE Attack Prophylactics Takhzyro, Haegarda, Cinryze
Posted on April 13, 20214/13/21
Meeting on the Meds | Ultra-Orphan Drugs Should Be First Area of Focus for Regulatory Alignment, Say Drug Regulators
Posted on April 9, 20214/9/21